Complete remission with romidepsin in a patient with T‐cell acute lymphoblastic leukemia refractory to induction hyper‐CVAD

T‐cell acute lymphoblastic leukemia (T‐ALL) and T‐cell lymphoblastic lymphoma (T‐LBL) are neoplasms that originate from T‐cell precursors. Outcomes in adult patients with T‐ALL/LBL remain unsatisfactory; early relapse following intensive induction chemotherapy is a concern, and patients with relapse...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunvand, Mark W., Carson, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836898/
https://www.ncbi.nlm.nih.gov/pubmed/28560733
http://dx.doi.org/10.1002/hon.2421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836898/
https://www.ncbi.nlm.nih.gov/pubmed/28560733
http://dx.doi.org/10.1002/hon.2421

Ejemplares similares